sur Affluent Medical (isin : FR0013333077)
Carvolix Strengthens Its Leadership Team
Carvolix, a French medical technology company, formerly known as Affluent Medical, has announced strategic changes to its leadership team. Anne Lange joins the Board of Directors, replacing Soad El Gazaoui. Lange brings extensive experience in innovation and digital transformation.
Additionally, Rute Fernandes has been appointed as a Board Observer, adding significant expertise in global commercial operations and rare diseases.
The company further enhances its advisory capabilities with the appointments of Paul LaViolette and Dr. Mirvat Alasnag to its advisory board, reinforcing Carvolix's scientific and clinical leadership.
Carvolix's governance structure now includes Liane Teplitsky as the Chair and Michel Therin as Vice Chair, strengthening its leadership team to support ambitious business goals. The company is recognized for its advancements in AI-driven mini-robots and biomimetic implants.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Affluent Medical